Hormone replacement therapy and the risk of colorectal cancer: A meta- analysis

Obstetrics and Gynecology

Volumn 93, Issue 5 SUPPL., 1999, Pages 880-888

  Nanda, Kavita ^a   Bastian, Lori A ^a   Hasselblad, Vic ^a   Simel, David L ^a  

^a D   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR;

ARTICLE; CANCER INHIBITION; CANCER RISK; CANCER SCREENING; CANCER SURVIVAL; COLORECTAL CANCER; DISEASE ASSOCIATION; DRUG EFFECT; DRUG MECHANISM; GENE SILENCING; HORMONE SUBSTITUTION; MENOPAUSE; META ANALYSIS; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 0032918794     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(98)00424-4     Document Type: Review

References (44)

1. Fraumeni J.F., Lloyd J.W., Smith E.M., Wagoner J.K. Cancer mortality among nuns; role of marital status in etiology of neoplastic disease in women. J Natl Cancer Inst. 42:1969;455-468.
2. McMichael A.J., Potter J.D. Reproduction, endogenous and exogenous sex hormones, and colon cancer A review and hypothesis . J Natl Cancer Inst. 65:1980;1201-1207.
3. Potter J.D. Hormones and colon cancer. J Natl Cancer Inst. 87:1995;1039-1040.
4. Burch J.C., Byrd B.F., Vaughn W.K. The effects of long-term estrogen administration to women following hysterectomy. Van Keep P.A., Lauritzen C. Estrogens in the post-menopause. Frontiers of hormone research. vol 3:1975;208-214 Karger, Basel.
5. Nachtigall L.E., Nachtigall R.H., Nachtigall R.D., Beckman E.M. Estrogen replacement therapy II A prospective study in the relationship to carcinoma and cardiovascular and metabolic problems . Obstet Gynecol. 54:1979;74-79.
6. Weiss N.S., Daling J.R., Chow W.H. Incidence of cancer of the large bowel in women in relation to reproductive and hormonal factors. J Natl Cancer Inst. 67:1981;57-60.
7. Potter J.D., McMichael A.J. Large bowel cancer in women in relation to reproductive and hormonal factors A case-control study . J Natl Cancer Inst. 71:1983;703-709.
8. Davis F.G., Furner S.E., Persky V., Koch M. The influence of parity and exogenous female hormones on the risk of colorectal cancer. Int J Cancer. 43:1989;587-590.
9. Furner S.E., Davis F.G., Nelson R.L., Haenszel W. A case-control study of large bowel cancer and hormone exposure in women. Cancer Res. 49:1989;4936-4940.
10. Peters R.K., Pike M.C., Chang W.W.L., Mack T.M. Reproductive factors and colon cancer. Br J Cancer. 61:1990;741-748.
11. Wu-Williams A.H., Lee M., Whittemore A.S., Gallagher R.P., Jiao D., Zheng S., et al. Reproductive factors and colorectal cancer risk among Chinese females. Cancer Res. 51:1991;2307-2311.
12. Gerhardsson de Verdier M., London S. Reproductive factors, exogenous female hormones, and colorectal cancer by subsite. Cancer Causes Control. 3:1992;355-360.
13. Jacobs E.J., White E., Weiss N.S. Exogenous hormones, reproductive history, and colon cancer (Seattle, Washington, USA). Cancer Causes Control. 5:1994;359-366.
14. Marcus P.M., Newcomb P.A., Young T., Storer B.E. The association of reproductive and menstrual characteristics and colon and rectal cancer risk in Wisconsin women. Ann Epidemiol. 5:1995;303-309.
15. Newcomb P.A., Storer B.E. Postmenopausal hormone use and risk of large-bowel cancer. J Natl Cancer Inst. 87:1995;1067-1071.
16. Fernandez E., LaVecchia C., D'Avanzo B., Franceschi S., Negri E., Parazzini F. Oral contraceptives, hormone replacement therapy and the risk of colorectal cancer. Br J Cancer. 73:1996;1431-1435.
17. Kampman E., Potter J.D., Slattery M.L., Caan B.J., Edwards S. Hormone replacement therapy, reproductive history, and colon cancer A multicenter, case-control study in the United States . Cancer Causes Control. 8:1997;146-158.
18. Hammond C.B., Jelovsek F.R., Lee K.L., Creasman W.T., Parker R.T. Effects of long-term estrogen replacement therapy II. Neoplasia. Am J Obstet Gynecol. 133:1979;537-547.
19. Wu A.H., Paganini-Hill A., Ross R.K., Henderson B.E. Alcohol, physical activity, and other risk factors for colorectal cancer A prospective study . Br J Cancer. 55:1987;687-694.
20. Adami H.O., Persson I., Hoover R., Schairer C., Bergkvist L. Risk of cancer in women receiving hormone replacement therapy. Int J Cancer. 44:1989;833-839.
21. Chute C.G., Willet W.D., Colditz G.A., Stampfer M.J., Rosner B., Speizer F. A prospective study of reproductive history and exogenous estrogens on the risk of colorectal cancer in women. Epidemiology. 2:1991;201-207.
22. Bostick R.M., Potter J.D., Kushi L.H., Sellers T.A., Steinmetz K.A., McKenzie D.R., et al. Sugar, meat, and fat intake, and non-dietary risk factors for colon cancer incidence in Iowa women (United States). Cancer Causes Control. 5:1994;38-52.
23. Folsom A.R., Mink P.J., Sellers T.A., Hong C.P., Zheng W., Potter J.D. Hormonal replacement therapy and morbidity and mortality in a prospective study of postmenopausal women. Am J Public Health. 85:1995;1128-1132.
24. Risch H.A., Howe G.R. Menopausal hormone use and colorectal cancer in Saskatchewan A record linkage cohort study . Cancer Epidemiol Biomarkers Prev. 4:1995;21-28.
25. Persson I., Yuen J., Bergkvist L., Schairer C. Cancer incidence and mortality in women receiving estrogen and estrogen-progestin replacement therapy - long-term follow-up of a Swedish cohort. Int J Cancer. 67:1996;327-332.
26. Troisi R., Schairer C., Chow W.H., Chow W.H., Schatzkin A., Brinton L.A., et al. A prospective study of menopausal hormones and risk of colorectal cancer. Cancer Causes Control. 8:1997;130-138.
27. Grodstein F., Martinez M.E., Giovannucci E.L., Colditz G.A., Hunter D.J., Willett W.C., et al. Postmenopausal hormone use and risk for colorectal cancer and adenoma. Ann Intern Med. 28:1998;705-712.
28. Calle E.E., Miracle-McMahill H.L., Thun M.J., Heath C.W. Estrogen replacement therapy and risk of fatal colon cancer in a prospective cohort of postmenopausal women. J Natl Cancer Inst. 87:1995;517-523.
29. Sturgeon S.R., Schairer C., Brinton L.A., Pearson T., Hoover R.N. Evidence of a healthy estrogen user survivor effect. Epidemiology. 6:1995;227-231.
30. Calle E.E. Hormone replacement therapy and colorectal cancer Interpreting the evidence . Cancer Causes Control. 8:1997;127-129.
31. MacLennan S.C., MacLennan A.H., Ryan P. Colorectal cancer and oestrogen replacement therapy. A meta-analysis of epidemiologic studies. Med J Aust. 162:1995;491-493.
32. Mulrow CD, Oxman AD, eds. Bias in non-experimental studies. Section 6.8, Cochrane Collaboration handbook [updated 1 March 1997]; In: The Cochrane Library [database on disk and CDROM]. The Cochrane Collaboration. Oxford: Update Software, 1996.
33. Hedges L.V., Olkin I. Statistical methods for meta-analysis. 1985;Academic Press, Orlando.
34. Eddy D.M., Hasselblad V., Schacter R. An introduction to a Bayesian method for meta-analysis. Med Decis Making. 10:1990;15-23.
35. Ries LAG, Kosary CL, Hankey BF, Miller BA, Harras A, Edwards BK (eds). SEER Cancer Statistics Review, 1973-1994, National Cancer Institute. National Institutes of Health Pub. No. 97-2789. Bethesda, Maryland, 1997.
36. Lointier P., Wildrick D.M., Boman B.M. The effects of steroid hormones on a human colon cancer line in vitro. Anticancer Res. 12:1992;1327-1330.
37. Xu X., Thomas M.L. Estrogen receptor-mediated direct stimulation of colon cancer cell growth in vitro. Mol Cell Endocrinol. 105:1994;197-201.
38. Harrison J.D., Watson S., Morris D.L. The effect of sex hormones and tamoxifen on the growth of human gastric and colorectal cancer lines. Cancer. 63:1989;2148-2151.
39. Di Leo A., Messa C., Russo F., Misciagna G., Guerra V., Taveri R., et al. Prognostic value of cytosolic estrogen receptors in human colorectal carcinoma and surrounding mucosa Preliminary results . Dig Dis Sci. 39:1994;2038-2042.
40. Issa J.P., Ottaviano Y.L., Celano P., Hamilton S.R., Davidson N.E., Baylin S.B. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet. 7:1994;536-540.
41. Potter J.D., Bostick R.M., Grandits G.A., Fosdick L., Elmer P., Wood J., et al. Hormone replacement therapy is associated with lower risk of adenomatous polyps of the large bowel The Minnesota cancer prevention research unit case-control study . Cancer Epidemiol Biomarkers Prev. 5:1996;779-784.
42. Jacobson J.S., Neugut A.I., Garbowski G.C., Ahsan H., Waye J.D., Treat M.R., et al. Reproductive risk factors for colorectal adenomatous polyps (New York City, NY, United States). Cancer Causes Control. 6:1995;513-518.
43. Peipins LA, Newman B, Sandler RS. Reproductive history, use of exogenous hormones, and risk of colorectal adenomas. Cancer Epidemiol Biomarkers Prev 1997 Sep;6:671-5.
44. Healthy People 2000 National health promotion and disease prevention objectives . 1992;Jones and Bartlett, Boston.